(BCS) Barclays - Ratings and Ratios
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US06738E2046
Banking, Cards, Lending, Investments, Wealth
Dividends
| Dividend Yield | 1.88% |
| Yield on Cost 5y | 7.16% |
| Yield CAGR 5y | 7.46% |
| Payout Consistency | 86.7% |
| Payout Ratio | 21.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.7% |
| Value at Risk 5%th | 50.1% |
| Relative Tail Risk | 2.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.76 |
| Alpha | 59.37 |
| CAGR/Max DD | 1.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.493 |
| Beta | 1.129 |
| Beta Downside | 1.209 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.96% |
| Mean DD | 7.02% |
| Median DD | 3.64% |
Description: BCS Barclays December 02, 2025
Barclays PLC (NYSE: BCS) is a globally diversified financial institution headquartered in London, operating across retail, corporate, private, investment, and U.S. consumer banking segments. Its product suite includes credit cards, wholesale and investment banking, wealth and investment management, and various lending services, with a heritage dating back to 1690.
Key metrics that analysts watch include a CET1 capital ratio of roughly 15% (Q3 2024), net interest income growth of 4% YoY driven by a rising European rate environment, and a loan-to-deposit ratio near 90%, reflecting balanced funding. Sector-wide, the bank’s performance is sensitive to central-bank policy shifts, regulatory capital requirements, and accelerating digital-banking adoption, which together shape revenue composition and cost efficiency.
For a deeper quantitative dive, consider exploring ValueRay’s analyst toolkit to benchmark Barclays against peers and assess scenario-based risk exposures.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (6.91b TTM) > 0 and > 6% of Revenue (6% = 1.64b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 0.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -809.9% (prev -820.9%; Δ 10.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 27.41b > Net Income 6.91b (YES >=105%, WARN >=100%) |
| Net Debt (-252.57b) to EBITDA (9.53b) ratio: -26.49 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.51b) change vs 12m ago -4.12% (target <= -2.0% for YES) |
| Gross Margin 6.97% (prev -33.73%; Δ 40.70pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.73% (prev 1.60%; Δ 0.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.01 (EBITDA TTM 9.53b / Interest Expense TTM 25.39b) >= 6 (WARN >= 3) |
Altman Z'' -0.72
| (A) -0.14 = (Total Current Assets 867.76b - Total Current Liabilities 1088.80b) / Total Assets 1629.15b |
| (B) 0.04 = Retained Earnings (Balance) 58.37b / Total Assets 1629.15b |
| (C) -0.00 = EBIT TTM -219.0m / Avg Total Assets 1580.14b |
| (D) 0.05 = Book Value of Equity 76.39b / Total Liabilities 1552.31b |
| Total Rating: -0.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.06
| 1. Piotroski 3.0pt |
| 2. FCF Yield -0.84% |
| 3. FCF Margin 20.30% |
| 4. Debt/Equity 1.88 |
| 5. Debt/Ebitda -26.49 |
| 6. ROIC - WACC (= -13.33)% |
| 7. RoE 9.25% |
| 8. Rev. Trend 42.33% |
| 9. EPS Trend 30.39% |
What is the price of BCS shares?
As of December 10, 2025, the stock is trading at USD 23.14 with a total of 4,472,592 shares traded.
Over the past week, the price has changed by +0.22%, over one month by +4.19%, over three months by +13.93% and over the past year by +75.49%.
Over the past week, the price has changed by +0.22%, over one month by +4.19%, over three months by +13.93% and over the past year by +75.49%.
Is BCS a buy, sell or hold?
Barclays has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy BCS.
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.7 | -6.4% |
| Analysts Target Price | 21.7 | -6.4% |
| ValueRay Target Price | 32.4 | 39.8% |
BCS Fundamental Data Overview December 09, 2025
Market Cap GBP = 60.46b (80.59b USD * 0.7502 USD.GBP)
P/E Trailing = 10.75
P/E Forward = 7.4627
P/S = 3.0977
P/B = 0.792
P/EG = 1.3097
Beta = 0.911
Revenue TTM = 27.29b GBP
EBIT TTM = -219.0m GBP
EBITDA TTM = 9.53b GBP
Long Term Debt = 121.50b GBP (from longTermDebt, last quarter)
Short Term Debt = 35.40b GBP (from shortTermDebt, last quarter)
Debt = 143.98b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -252.57b GBP (from netDebt column, last quarter)
Enterprise Value = -663.10b GBP (60.46b + Debt 143.98b - CCE 867.54b)
Interest Coverage Ratio = -0.01 (Ebit TTM -219.0m / Interest Expense TTM 25.39b)
FCF Yield = -0.84% (FCF TTM 5.54b / Enterprise Value -663.10b)
FCF Margin = 20.30% (FCF TTM 5.54b / Revenue TTM 27.29b)
Net Margin = 25.33% (Net Income TTM 6.91b / Revenue TTM 27.29b)
Gross Margin = 6.97% ((Revenue TTM 27.29b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = -0.41 (set to none) (Enterprise Value -663.10b / Total Assets 1629.15b)
Interest Expense / Debt = 17.63% (Interest Expense 25.39b / Debt 143.98b)
Taxrate = 17.57% (365.0m / 2.08b)
NOPAT = -180.5m (EBIT -219.0m * (1 - 17.57%)) [loss with tax shield]
Current Ratio = 0.80 (Total Current Assets 867.76b / Total Current Liabilities 1088.80b)
Debt / Equity = 1.88 (Debt 143.98b / totalStockholderEquity, last quarter 76.39b)
Debt / EBITDA = -26.49 (Net Debt -252.57b / EBITDA 9.53b)
Debt / FCF = -45.60 (Net Debt -252.57b / FCF TTM 5.54b)
Total Stockholder Equity = 74.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.42% (Net Income 6.91b / Total Assets 1629.15b)
RoE = 9.25% (Net Income TTM 6.91b / Total Stockholder Equity 74.75b)
RoCE = -0.11% (EBIT -219.0m / Capital Employed (Equity 74.75b + L.T.Debt 121.50b))
RoIC = -0.09% (negative operating profit) (NOPAT -180.5m / Invested Capital 208.25b)
WACC = 13.25% (E(60.46b)/V(204.44b) * Re(10.18%) + D(143.98b)/V(204.44b) * Rd(17.63%) * (1-Tc(0.18)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -51.77%
[DCF Debug] Terminal Value 61.47% ; FCFE base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 6.89 (DCF Value 23.90b / Shares Outstanding 3.47b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 30.39 | EPS CAGR: 12.52% | SUE: -0.54 | # QB: 0
Revenue Correlation: 42.33 | Revenue CAGR: 8.98% | SUE: 0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=2.85 | Chg30d=-0.092 | Revisions Net=-1 | Growth EPS=+23.2% | Growth Revenue=+5.2%
P/E Trailing = 10.75
P/E Forward = 7.4627
P/S = 3.0977
P/B = 0.792
P/EG = 1.3097
Beta = 0.911
Revenue TTM = 27.29b GBP
EBIT TTM = -219.0m GBP
EBITDA TTM = 9.53b GBP
Long Term Debt = 121.50b GBP (from longTermDebt, last quarter)
Short Term Debt = 35.40b GBP (from shortTermDebt, last quarter)
Debt = 143.98b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -252.57b GBP (from netDebt column, last quarter)
Enterprise Value = -663.10b GBP (60.46b + Debt 143.98b - CCE 867.54b)
Interest Coverage Ratio = -0.01 (Ebit TTM -219.0m / Interest Expense TTM 25.39b)
FCF Yield = -0.84% (FCF TTM 5.54b / Enterprise Value -663.10b)
FCF Margin = 20.30% (FCF TTM 5.54b / Revenue TTM 27.29b)
Net Margin = 25.33% (Net Income TTM 6.91b / Revenue TTM 27.29b)
Gross Margin = 6.97% ((Revenue TTM 27.29b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = -0.41 (set to none) (Enterprise Value -663.10b / Total Assets 1629.15b)
Interest Expense / Debt = 17.63% (Interest Expense 25.39b / Debt 143.98b)
Taxrate = 17.57% (365.0m / 2.08b)
NOPAT = -180.5m (EBIT -219.0m * (1 - 17.57%)) [loss with tax shield]
Current Ratio = 0.80 (Total Current Assets 867.76b / Total Current Liabilities 1088.80b)
Debt / Equity = 1.88 (Debt 143.98b / totalStockholderEquity, last quarter 76.39b)
Debt / EBITDA = -26.49 (Net Debt -252.57b / EBITDA 9.53b)
Debt / FCF = -45.60 (Net Debt -252.57b / FCF TTM 5.54b)
Total Stockholder Equity = 74.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.42% (Net Income 6.91b / Total Assets 1629.15b)
RoE = 9.25% (Net Income TTM 6.91b / Total Stockholder Equity 74.75b)
RoCE = -0.11% (EBIT -219.0m / Capital Employed (Equity 74.75b + L.T.Debt 121.50b))
RoIC = -0.09% (negative operating profit) (NOPAT -180.5m / Invested Capital 208.25b)
WACC = 13.25% (E(60.46b)/V(204.44b) * Re(10.18%) + D(143.98b)/V(204.44b) * Rd(17.63%) * (1-Tc(0.18)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -51.77%
[DCF Debug] Terminal Value 61.47% ; FCFE base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 6.89 (DCF Value 23.90b / Shares Outstanding 3.47b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 30.39 | EPS CAGR: 12.52% | SUE: -0.54 | # QB: 0
Revenue Correlation: 42.33 | Revenue CAGR: 8.98% | SUE: 0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=2.85 | Chg30d=-0.092 | Revisions Net=-1 | Growth EPS=+23.2% | Growth Revenue=+5.2%
Additional Sources for BCS Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle